The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
AimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/full |
_version_ | 1797942041433341952 |
---|---|
author | Bingshi Zhang Xiao Chen Xiaowei Yao Mengnan Li Zhijie Li Bo Liu Sikai Liu Zeming Liu Jia Huo Yongtai Han |
author_facet | Bingshi Zhang Xiao Chen Xiaowei Yao Mengnan Li Zhijie Li Bo Liu Sikai Liu Zeming Liu Jia Huo Yongtai Han |
author_sort | Bingshi Zhang |
collection | DOAJ |
description | AimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS.ResultsThe most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0).ConclusionThis is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected. |
first_indexed | 2024-04-10T20:01:22Z |
format | Article |
id | doaj.art-569744c34c11481daa4814bb90b7e8ed |
institution | Directory Open Access Journal |
issn | 2235-2988 |
language | English |
last_indexed | 2024-04-10T20:01:22Z |
publishDate | 2023-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cellular and Infection Microbiology |
spelling | doaj.art-569744c34c11481daa4814bb90b7e8ed2023-01-27T05:13:43ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-01-011310.3389/fcimb.2023.11060971106097The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitisBingshi Zhang0Xiao Chen1Xiaowei Yao2Mengnan Li3Zhijie Li4Bo Liu5Sikai Liu6Zeming Liu7Jia Huo8Yongtai Han9Department of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Orthopedics, The Chest Hospital of Hebei Province, Shijizhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaOrthopedics Department, Affiliated Hospital of Hebei Engineering University, Handan, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaDepartment of Osteonecrosis and Hip Surgery, The Third Hospital of Hebei Medical, Shijiazhuang, Hebei, ChinaAimsThis study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO).MethodsThis retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS.ResultsThe most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0).ConclusionThis is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected.https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/fulldiagnostic testmetagenomic next-generation sequencing (mNGS)infectionosteomyelitis (OM)blood |
spellingShingle | Bingshi Zhang Xiao Chen Xiaowei Yao Mengnan Li Zhijie Li Bo Liu Sikai Liu Zeming Liu Jia Huo Yongtai Han The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis Frontiers in Cellular and Infection Microbiology diagnostic test metagenomic next-generation sequencing (mNGS) infection osteomyelitis (OM) blood |
title | The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis |
title_full | The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis |
title_fullStr | The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis |
title_full_unstemmed | The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis |
title_short | The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis |
title_sort | diagnostic value of blood metagenomic next generation sequencing in patients with acute hematogenous osteomyelitis |
topic | diagnostic test metagenomic next-generation sequencing (mNGS) infection osteomyelitis (OM) blood |
url | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1106097/full |
work_keys_str_mv | AT bingshizhang thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT xiaochen thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT xiaoweiyao thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT mengnanli thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT zhijieli thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT boliu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT sikailiu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT zemingliu thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT jiahuo thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT yongtaihan thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT bingshizhang diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT xiaochen diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT xiaoweiyao diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT mengnanli diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT zhijieli diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT boliu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT sikailiu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT zemingliu diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT jiahuo diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis AT yongtaihan diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis |